Overview: Myoglobin TestIntroduction: The Myoglobin Test measures myoglobin to diagnose muscle damage or heart attack, causing chest pain or weakness. Following 2023 ACC guidelines, it uses immunoassay for high specificity, supporting cardiac screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected rhabdomyolysis or myocardial infarction.
Other Names: Myoglobin Assay, Muscle Damage Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Myoglobin testing began in the 1970s with cardiac and muscle research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures myoglobin to diagnose muscle damage or heart attack, guides treatment, and evaluates patients with chest pain or weakness.
Test Parameters: 1. Myoglobin Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum, plasma, or urine. Report history of chest pain, weakness, or muscle trauma.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document chest pain, weakness, muscle trauma, or history of cardiac events. Include current medications, especially statins.
Consent: Written consent required, detailing the tests purpose, muscle or cardiac damage implications, and risks of sample collection.
Procedural Considerations: Uses immunoassay to measure myoglobin in serum, plasma, or urine. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for muscle or cardiac damage diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Recent exercise or trauma may elevate levels.
Clinical Significance: Elevated myoglobin confirms muscle damage or heart attack, guiding supportive care or cardiac intervention. Normal levels may require troponin testing.
Specialist Consultation: Consult a cardiologist or neurologist for result interpretation and treatment planning.
Additional Supporting Tests: Troponin, CK-MB, or ECG to confirm heart attack or rhabdomyolysis diagnosis.
Test Limitations: Not specific to cardiac or muscle damage; clinical correlation is needed. Timing of sample collection affects accuracy.
References: ACC Cardiac Guidelines, 2023; Circulation, Thygesen K, 2022.
